Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation
about
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with TemozolomideVasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Emerging targets for glioblastoma stem cell therapy
P2860
Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@ast
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@en
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@nl
type
label
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@ast
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@en
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@nl
prefLabel
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@ast
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@en
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@nl
P2093
P2860
P1433
P1476
Unique anti-glioblastoma activ ...... in tumor cell differentiation
@en
P2093
Mathilda Mandel
Naama Dror
P2860
P304
P356
10.1371/JOURNAL.PONE.0073625
P407
P577
2013-01-01T00:00:00Z